[Pj-56] Japanese Poster Session 56
Headache/other 2

[Pj-56-1] Functioning and disability among migraine patients: a long-term, open-label study of galcanezumab

^○Tomomi Nakamura¹, Peter Mcallister², Janet H. Ford³, Virginia L. Stauffer³, Matthew Sexson³, David W. Ayer³, Shufang Wang³ (1.Eli Lilly Japan K.K., Kobe, Japan, 2.New England Institute for Neurology and Headache, Stamford, CT, USA, 3.Eli Lilly and Company, Indianapolis, IN, USA)